Karen A. Hicks

All filings by Karen A. Hicks on record concern Gyre Therapeutics, Inc. In total, 16 filings cover trades dated from 13 May 2010 to 1 March 2011.

On the market, this insider has only sold: 7 sales, €768k in total. The rest of the record consists of 9 option exercises. In 2011 alone, the filings show no purchases and 5 sales.

The latest filing, published on 3 March 2011, reports an option exercise of €2,817 in Gyre Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.